Results for tag: "Atrial Flutter Drug"

Atrial flutter is a type of cardiac arrhythmia, or irregular heartbeat, that affects the atria of the heart. It is caused by a rapid, disorganized electrical activity in the atria, resulting in an abnormal heart rate. Treatment for atrial flutter typically involves medications to control the heart rate and rhythm, as well as lifestyle changes. Commonly prescribed drugs for atrial flutter include beta-blockers, calcium channel blockers, and antiarrhythmic drugs. The atrial flutter drug market is a segment of the larger cardiovascular drug market, which includes drugs used to treat a variety of heart conditions. The atrial flutter drug market is expected to grow in the coming years due to the increasing prevalence of cardiovascular diseases and the growing demand for effective treatments. Some companies in the atrial flutter drug market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more